| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 1 |
| 1 | ADO-TRASTUZUMAB EMTANSINE | 1 |
| 2 | ALECTINIB HYDROCHLORIDE | 1 |
| 3 | BEVACIZUMAB | 1 |
| 4 | BRIGATINIB | 1 |
| 5 | CARBOPLATIN | 1 |
| 6 | DALTEPARIN SODIUM | 1 |
| 7 | DOCETAXEL | 1 |
| 8 | DOCETAXEL ANHYDROUS | 1 |
| 9 | DULAGLUTIDE | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BRIGATINIB | 1 | 0.0003 |
| 1 | ALECTINIB HYDROCHLORIDE | 1 | 0.0001 |
| 2 | ADO-TRASTUZUMAB EMTANSINE | 1 | 0.0001 |
| 3 | GEFITINIB | 1 | 0.0001 |
| 4 | DALTEPARIN SODIUM | 1 | 0.0001 |
| 5 | PERTUZUMAB | 1 | 0.0000 |
| 6 | DOCETAXEL ANHYDROUS | 1 | 0.0000 |
| 7 | DOCETAXEL | 1 | 0.0000 |
| 8 | TRASTUZUMAB | 1 | 0.0000 |
| 9 | SOMATROPIN | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Recombinant Human Growth Hormone [EPC] | 1 | 0.0000 |
| 1 | HER2/neu Receptor Antagonist [EPC] | 1 | 0.0000 |
| 2 | Microtubule Inhibitor [EPC] | 2 | 0.0000 |
| 3 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 1 | 0.0000 |
| 4 | Platinum-based Drug [EPC] | 1 | 0.0000 |
| 5 | Kinase Inhibitor [EPC] | 2 | 0.0000 |
| 6 | GLP-1 Receptor Agonist [EPC] | 1 | 0.0000 |